Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm S (Q58492145)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm S	article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

decision making

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

Giuseppe Boriani

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Charles J. Ferro

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Gaetano La Manna

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

13

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

7

object named as

Deirdre A Lane

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Irina Savelieva

2

object named as

Irina Savelieva

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Gheorghe-Andrei Dan

3

object named as

Gheorghe-Andrei Dan

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

11

object named as

Marc A Vos

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Jean Claude Deharo

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Joseph Morton

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Angel Moya Mitjans

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Carsten W Israel

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Mintu P Turakhia

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Document reviewers

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

0 references

publication date

24 June 2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

1169-1196

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Evolving importance of kidney disease: from subspecialty to global health burden

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal dysfunction and heart failure: things are seldom what they seem

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Current and novel renal biomarkers in heart failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence and factors associated with CKD: a population study from Beijing

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lif

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of chronic kidney disease in the Japanese general population.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of chronic kidney disease in population-based studies: systematic review

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Arterial stiffness in chronic kidney disease: causes and consequences

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Arterial disease in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Epidemiology of atrial fibrillation: European perspective

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systemsThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

An update on the prognosis of patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry

2 references

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Cor

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Long-term outcomes in nondiabetic chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Lifestyle factors, obesity and the risk of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A predictive model for progression of chronic kidney disease to kidney failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Arrhythmias in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Risk of sudden cardiac death in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Serum potassium and arrhythmias.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Meta-analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Comparison of CHADS 2 , R 2 CHADS 2 , and CHA 2 DS 2 -VASc Scores for the Prediction of Rhythm Outcomes After Catheter Ablation of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Atrial fibrillation in hypertension: predictors and outcome

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Incidence and risk of atrial fibrillation in sleep-disordered breathing without coexistent systemic disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Obstructive sleep apnea may increase the risk of stroke in AF patients: Refining the CHADS2 score

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Alcohol Consumption and Risk of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Alcohol intake and prognosis of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Body mass index and adverse events in patients with incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Kidney dysfunction and sudden cardiac death among women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

How to reduce sudden cardiac death in patients with renal failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The treatment of coronary artery disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Left ventricular mass in chronic kidney disease and ESRD.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Left ventricular hypertrophy in nondiabetic predialysis CKD.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Incremental prognostic value of an abnormal baseline spatial QRS-T angle in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Sympathetic overactivity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

A limited renal injury may cause a permanent form of neurogenic hypertension.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The current status of interventions aiming at reducing sudden cardiac death in dialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiac arrest and sudden death in dialysis units

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Beta-blockers in congestive heart failure. A Bayesian meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Beta-blockers for coronary heart disease in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

In-Center Hemodialysis Six Times per Week versus Three Times per Week

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Management of atrial fibrillation in chronic kidney disease: double trouble

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Intradialytic hypotension and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Symptomatic Intradialytic Hypotension and Mortality: An Opinionated Review

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Association of mortality risk with various definitions of intradialytic hypotension

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Rate control in atrial fibrillation: choice of treatment and assessment of efficacy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Catheter ablation of atrial fibrillation: an update

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: A mid-term follow-up

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The impact of haemodialysis on the outcomes of catheter ablation in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of A

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiovascular disease and CKD: core curriculum 2010.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Perioperative Management of the Hemodialysis Patient

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Hyperkalemia induced failure of atrial and ventricular pacemaker capture

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Device Therapy in Heart Failure Patients With Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Influence of renal function on the use of guideline-recommended therapies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial—Cardiac Resynchronization Therapy (MADIT-CRT)

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiac resynchronization therapy in CKD: a systematic review

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Renal dysfunction and clinical outcomes of patients undergoing ICD and CRTD implantation: data from the Israeli ICD registry

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Aspects of immune dysfunction in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

End-Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Transvenous Cardiac Implantable Electronic Devices and Hemodialysis Catheters: Recommendations to Curtail a Potentially Lethal Combination

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Reimbursement of dialysis: a comparison of seven countries

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Economic evaluation in cardiology

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Cost-effectiveness of cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA).

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Chronic kidney disease: global dimension and perspectives

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

Prevalence of Chronic Kidney Disease in Patients Undergoing Cardiac Rhythm Device Removal

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUV202

21 January 2018

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of survival after cardiac arrest in outpatient hemodialysis clinics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of sudden death relative to the hemodialysis procedure

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in patients on renal replacement therapy and permanent cardiac pacemakers

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationw

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predisposition to Arrhythmias: Electrolytes, Uremic Fibrosis, Other Factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function and mortality following cardiac resynchronization therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular mortality in children and young adults with end-stage kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in the prevention and management of intradialytic hypotension

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of sudden death in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart-Kidney Interaction: Epidemiology of Cardiorenal Syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperkalemia-induced failure of atrial capture during dual-chamber cardiac pacing

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transvenous Cardiac Device Wires and Vascular Access in Hemodialysis Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of chronic renal disease in Spain: results of the EPIRCE study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular hypertrophy in the renal patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrolyte disorders and arrhythmogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrial fibrillation: the beat is faster than the answers

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction: chronic kidney disease: a burgeoning health epidemic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of sudden cardiac death with inflammation and other traditional risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hypertension on anticoagulated patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sudden and cardiac death rates in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management

1 reference

https://pubmed.ncbi.nlm.nih.gov/26108808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EUROPACE/EUV202

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108808 AND SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58492145&oldid=1866108288"